Alkermes
ALKS
#3093
Rank
A$7.33 B
Marketcap
A$44.44
Share price
0.75%
Change (1 day)
-8.10%
Change (1 year)

Alkermes (ALKS) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : A$0.89 Billion

According to Alkermes's latest financial reports the company's total liabilities are A$0.89 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Alkermes - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31A$0.94 B-30.7%
2023-12-31A$1.37 B1.33%
2022-12-31A$1.35 B7.51%
2021-12-31A$1.25 B9.56%
2020-12-31A$1.14 B11.64%
2019-12-31A$1.02 B10.81%
2018-12-31A$0.92 B21.88%
2017-12-31A$0.76 B6.17%
2016-12-31A$0.71 B-3.51%
2015-12-31A$0.74 B16.48%
2014-12-31A$0.63 B
2013-03-31A$0.49 B-11.19%
2012-03-31A$0.56 B857.74%
2011-03-31A$58.47 M-47.72%
2010-03-31A$0.11 B-40.58%
2009-03-31A$0.18 B-50.6%
2008-03-31A$0.38 B-15.68%
2007-03-31A$0.45 B-28.14%
2006-03-31A$0.62 B45.19%
2005-03-31A$0.43 B68.16%
2004-03-31A$0.25 B-40.4%
2003-03-31A$0.43 B-8.01%
2002-03-31A$0.46 B-6.51%
2001-03-31A$0.50 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Acorda Therapeutics
ACOR
A$0.40 B-55.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$117.86 B 13,033.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$170.93 B 18,947.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$174.08 B 19,299.24%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$103.10 B 11,389.23%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
A$49.08 B 5,369.40%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Sanofi
SNY
A$99.40 B 10,976.89%๐Ÿ‡ซ๐Ÿ‡ท France
Novartis
NVS
A$94.14 B 10,391.38%๐Ÿ‡จ๐Ÿ‡ญ Switzerland